The following information is NOT meant to be used to treat yourself or patients
- Generic name = Milnacipran
pdr.net - Trade name = Savella
- Class = “antidepressant” (selective serotonin and norepinephrine reuptake inhibitors)
- Advantages
- Shown effective for fibromyalgia
- Dosing
- Fibromyalgia
- Day 1: 12.5 mg x 1
- Day 2-3: 12.5 mg BID
- Day 4-7: 25 mg BID
- Thereafter: 50 mg BID
- Max dose: 100 mg BID
- Adequate trial period: 4 weeks
- Fibromyalgia
- Note: Decreased dose in patients with renal disease
Milnacipran might be SNRI but it has no effect on pain conditions.
I advice to update your page.
Cochrane Database Syst Rev. 2015 Jul 6;(7):CD011789. doi: 10.1002/14651858.CD011789.
Milnacipran for neuropathic pain in adults.
There was no evidence to support the use of milnacipran to treat neuropathic pain conditions.